Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration CaseBusiness Wire • 10/16/22
Alkermes Announces Launch of 5th Annual Alkermes Pathways Research Awards® ProgramPRNewsWire • 09/28/22
Alkermes (ALKS) Could Find Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 08/11/22
Alkermes (ALKS) Loses 16.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 08/01/22
Alkermes plc (ALKS) CEO Richard Pops on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/27/22